Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02238496
Recruitment Status : Active, not recruiting
First Posted : September 12, 2014
Last Update Posted : April 23, 2019
Sponsor:
Collaborators:
Pfizer
AEterna Zentaris
Information provided by (Responsible Party):
Andrew B Lassman, MD, Columbia University

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : October 27, 2017
  Estimated Study Completion Date : August 31, 2019